Results 241 to 250 of about 104,267 (299)

Pharmacogenetic and microRNA mechanisms of beta blocker use on bone. [PDF]

J Bone Miner Res
Lary CW, Atkinson EJ, Spillane J, Nayema Z, Roy TA, Peters R, Scott GT, Chen H, Nagarajan A, Brown A, Motyl KJ, Monroe DG, Khosla S.   +12 more
europepmc   +1 more source

Pre-admission beta-blocker therapy and outcomes in cardiogenic shock: Insights from the Altshock-2 Registry. [PDF]

ESC Heart Fail
Pagnesi M, Riccardi M, Sacco A, Tavecchia G, Viola G, Frea S, Briani M, Bertoldi LF, Bertaina M, Potena L, Valente S, Marini M, De Ferrari GM, D'Ettore N, Cardinale A, Camporotondo R, Rota M, Tavazzi G, Morici N, Pappalardo F, Metra M, Altshock‐2 investigators.   +21 more
europepmc   +1 more source

Utility of Cardiopulmonary Exercise Testing in Assessing Beta-Blocker Efficacy in LQTS: Moving Away From One-Size-Fits-All. [PDF]

J Cardiovasc Electrophysiol
El Assaad I, Heilbronner AK, Zahka K, Hammond B, Patel A, Aziz PF.   +5 more
europepmc   +1 more source

Beta blocker use and breast cancer survival by subtypes: A population-based cohort study. [PDF]

Breast
Scott OW, Tin Tin S, Botteri E.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Beta-Blockers for Hemangiomas

2015
Infantile hemangiomas (IHs) are the most common tumors in infancy. Their typical natural history is characterized by an early rapid growth in the first months of life and by a slow spontaneous involution in the first years of life. Even though spontaneous regression of IHs could suggest therapeutic abstention, systemic treatment is the therapy of ...
C. Gelmetti, R. Cavalli
openaire   +3 more sources

The vasodilatory beta-blockers

Current Hypertension Reports, 2007
Although well established in treating hypertension and cardiovascular (CV) disease, clinical trial data suggest that beta-blockers (eg, atenolol) may be less effective than other antihypertensive classes in reducing stroke and CV mortality despite similar blood pressure (BP) reductions.
Michala E, Pedersen, John R, Cockcroft
openaire   +2 more sources

Asthma and beta-blockers

European Journal of Clinical Pharmacology, 1982
In a randomized, blind crossover study in 14 hypertensive patients with asthma, involving placebo and chronically administered (3 weeks) equipotent beta1-blocking doses of atenolol 100 mg once daily and metoprolol 100 mg bid, atenolol and metoprolol produced a similar fall in blood pressure.
D S, Lawrence, J N, Sahay, S S, Chatterjee, J M, Cruickshank   +3 more
openaire   +2 more sources

Beta blockers in pregnancy

BJOG: An International Journal of Obstetrics & Gynaecology, 1981
DRUGS that competitively antagonize the effects of catecholamines at beta-adrenoreceptors have been in clinical use since the mid-1960s.
openaire   +3 more sources

Preinjury beta blocker usage does not affect the heart rate response to initial trauma resuscitation

International Journal of Surgery, 2012
BackgroundThe effect of preinjury beta blockade on heart rate during initial trauma resuscitation is unclear. We hypothesized that preinjury beta blockade does not affect the heart rate response to initial trauma resuscitation.MethodsA case-control study
Joaquim M Havens, Xiangmei Gu, Selwyn O Rogers   +2 more
exaly   +2 more sources

Beta-Blockers in Psychiatry

Psychiatric Services, 1984
Beta-adrenergic receptor blocking drugs, although not approved by the Food and Drug Administration for treatment of psychiatric disorders, have been used with increasing success in psychiatry. Many beta-blockers are now available, but only those that have high lipid solubility and thus readily penetrate the brain, such as propranolol and oxprenolol ...
R A, Dominguez, B J, Goldstein
openaire   +2 more sources